Sentence examples for reduced cell count from inspiring English sources

When we studied the effect of psammaplin A on the viability of macrophage cell line RAW264.7, a reduced cell count was observed in the psammaplin A-treated cells and this decrease in the number of living cells also showed good dose-dependent (Fig 2).

Significant parts of GTVMRI/CT that showed hyperintensity but not enhancing tracer were excluded from the high-dose volume and were assumed to represent fibrosis, necrosis, or scarring after surgery and/or radiotherapy with reduced cell count based on investigator's experience, clinical information and available data [ 5, 6].

Similarly, knockdown of c-Src in Caco2 cells reduced cell counts by 20% in normoxia compared to a more significant 58% reduction in hypoxia.

In contrast, K-ras knockdown in hypoxic conditions reduced cell counts to a much greater extent: a 40% reduction in HCT116 (P<0.05) and 50% reductions in DLD1 and Caco2 cells (P<0.01) were observed (Fig. 4A).

All miR-211-expressing cultures of WM1552C/211 showed reduced cell counts compared to those of WM1552C beginning at even the first time point (day 4), and the titre continued to fall behind as time progressed.

Shah et al (1999) reported moderate effects of healing in the expected direction, that is, reduced cell counts, for four different tumour cell lines.

We developed novel nonpeptidic inhibitors of important MRP subtypes related to both MRP-mediated resistances as well as reduced cell counts.

Preventive olodaterol treatment dose dependently reduced cell counts with a maximal effect at the highest dose of 1.0 mg·mL−1 attenuating the total cell count by 60% and the neutrophilic cell count by 69%.

At stem cell kill rates lower than 0.005 h-1 the rapid loss of S and CG is compensated by increased proliferative fractions and amplifications resulting in only slightly reduced cell counts of circulating granulocytes (GRA).

Caspase-3-deficient EVs induced less cytokine/MIP-2 release, reduced cell counts in BALF, less neutrophil infiltration and less inflammation in lung parenchyma, both in vitro and in vivo.

The majority of inhibitors tested on EGF-stimulated PMC42-ET cells were efficacious at reducing cell count; however, nearly every inhibitor tested had an IC50 for reducing the number of vimentin+ cells well above pharmacologically relevant concentrations (Table  3 a- e), thus off-target effects are likely.